Safety Assessment of <i>Camellia sinensis–</i>Derived Ingredients As Used in Cosmetics

DOI Web Site Web Site 被引用文献1件
  • Lillian C. Becker
    Cosmetic Ingredient Review Former Scientific Analyst/Writer, Cosmetic Ingredient Review, Washington, DC, USA
  • Wilma F. Bergfeld
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Donald V. Belsito
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Ronald A. Hill
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Curtis D. Klaassen
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Daniel C. Liebler
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • James G. Marks
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Ronald C. Shank
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Thomas J. Slaga
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Paul W. Snyder
    Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
  • Lillian J. Gill
    Cosmetic Ingredient Review Former Director, Cosmetic Ingredient Review, Washington, DC, USA
  • Bart Heldreth
    Cosmetic Ingredient Review Executive Director, Cosmetic Ingredient Review, Washington, DC, USA

この論文をさがす

説明

<jats:p> Cosmetic ingredients derived from Camellia sinensis (tea) plant parts function as antioxidants and skin conditioning agents—humectant and miscellaneous. The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed relevant animal and human data related to these ingredients. The use of the leaf ingredients in beverages results in much larger systemic exposures than those possible from cosmetic use. Accordingly, concern over the systemic toxicity potential of leaf-derived ingredients is mitigated. Because product formulations may contain multiple botanical ingredients, each containing the same constituents of concern, formulators are advised to be aware of these constituents and to avoid reaching levels that may lead to sensitization or other toxic effects. The Panel concluded that the C sinensis leaf-derived ingredients are safe in the present practices of use and concentration described in this safety assessment when formulated to be nonsensitizing. However, the available data are insufficient to determine whether the non-leaf-derived ingredients are safe for use in cosmetics. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ